Bioavailability, Metabolism, and Health Effects of Phenolic Compounds

A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Biochemistry and Molecular Biology".

Deadline for manuscript submissions: 28 February 2025 | Viewed by 937

Special Issue Editors


E-Mail Website
Guest Editor
Department of Life Sciences, University of Modena and Reggio Emilia, Via Amendola 2, 42100 Reggio Emilia, Italy
Interests: phenolic compounds; biological activity; intestinal microbiota; cancer; diabetes; cardiovascular diseases; mass spectrometry; gastrointestinal digestion

Special Issue Information

Dear Colleagues,

Fruit and vegetable intake has been associated with reducing the onset of several chronic diseases, such as cardiovascular diseases and cancer. Phenolic compounds, abundantly present in these foods, are considered the molecular effectors of these health-promoting effects. A growing body of evidence from both in vivo and in vitro studies suggests that a high intake of these compounds may be protective against several diseases, including cancer, cardiovascular and neurodegenerative diseases, and diabetes. The health effects of phenolic compounds are related to their biological properties, including their ability to interact with enzymes and metabolic pathways involved in human pathologies, beyond their antioxidant properties.

Once ingested, phenolic compounds must be released from the food matrix to make them available for intestinal absorption. Only a small portion of ingested phenolic compounds is absorbed at the intestinal level, while most of them reach the colon, fundamentally modified by the colonic flora, producing low-molecular-weight metabolites that are further absorbed, reaching the systemic circulation. Additionally, endogenous metabolism at intestinal and hepatic levels may further modify the structure of phenolic compounds. Therefore, not only the parent phenolic compounds found in vegetables but also endogenous and colonic metabolites may be responsible for the protective effects of these molecules on human health.

This Special Issue aims to collect research and review articles encompassing all the aspects related to the gastrointestinal fate, absorption, metabolism, gut microbiota interaction, and health properties of phenolic compounds and their metabolites. Both in vivo and in vitro studies on these topics are welcomed. The scope of this Special Issue is to contribute to advancing scientific research in an exciting and rapidly growing field of research with significant implications for human health.

Dr. Davide Tagliazucchi
Dr. Alice Cattivelli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • phenolic compounds
  • gut microbiota
  • metabolism
  • cardiovascular diseases
  • cancer
  • anti-proliferative activity
  • bioavailability
  • bioaccessibility

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 3107 KiB  
Article
Resveratrol and (-)-Epigallocatechin-3-gallate Regulate Lipid Metabolism by Activating the AMPK Pathway in Hepatocytes
by Huanbin Wang, Yu An, Shahid Ali Rajput and Desheng Qi
Biology 2024, 13(6), 368; https://0-doi-org.brum.beds.ac.uk/10.3390/biology13060368 - 23 May 2024
Viewed by 664
Abstract
The purpose of this study was to explore the effects of Res and EGCG on cell growth, cellular antioxidant levels, and cellular lipid metabolism in hepatocytes. In this experiment, leghorn male hepatoma (LMH) cells were used as hepatocytes. The results showed that 6.25–25 [...] Read more.
The purpose of this study was to explore the effects of Res and EGCG on cell growth, cellular antioxidant levels, and cellular lipid metabolism in hepatocytes. In this experiment, leghorn male hepatoma (LMH) cells were used as hepatocytes. The results showed that 6.25–25 μM Res and EGCG had no adverse effects on cell viability and growth. Meanwhile, with the increasing dosage of Res and EGCG, the contents of total cholesterol (TC), total glyceride (TG), and malondialdehyde (MDA) in hepatocytes decreased significantly (p < 0.05), while the contents of glutathione peroxidase (GSH-Px), total superoxide dismutase (T-SOD), and catalase (CAT) increased significantly (p < 0.05). In addition, western blot results showed that Res and EGCG could significantly increase the expression of p-AMPK protein and reduce the expression of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) protein in hepatocytes (p < 0.05). Moreover, q-PCR results showed that with the increase in Res and EGCG, the expression of cholesterol- and fatty acid synthesis-related genes decreased significantly (p < 0.05). In conclusion, Res and EGCG can increase the antioxidant capacity of hepatocytes and reduce the synthesis of TC and TG in hepatocytes by activating AMPK, thereby regulating lipid metabolism in hepatocytes. Full article
(This article belongs to the Special Issue Bioavailability, Metabolism, and Health Effects of Phenolic Compounds)
Show Figures

Figure 1

Back to TopTop